Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Perspective Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
105
+2 vs. Q1 2024
Shares held
38.7M
−208.9M (−84.4%) vs. Q1 2024
Total value
$384.9M
+$90.4M (+30.7%) vs. Q1 2024
New holders
51
9 more added
Sold out
49
44 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 105 institutions
Q1 2021: 57 institutionsQ2 2021: 48 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 39 institutionsQ2 2022: 43 institutionsQ3 2022: 35 institutionsQ4 2022: 48 institutionsQ1 2023: 42 institutionsQ2 2023: 50 institutionsQ3 2023: 49 institutionsQ4 2023: 52 institutionsQ1 2024: 104 institutionsQ2 2024: 105 institutionsQ3 2024: 127 institutionsQ4 2024: 135 institutionsQ1 2025: 112 institutionsQ2 2025: 98 institutionsQ3 2025: 105 institutionsQ4 2025: 117 institutionsQ1 2026: 138 institutionsQ2 2026: 131 institutions
Value heldQ2 2024: $384.9M
Q1 2021: $20.2MQ2 2021: $13.9MQ3 2021: $9.99MQ4 2021: $6.78MQ1 2022: $5.79MQ2 2022: $5.19MQ3 2022: $3.70MQ4 2022: $4.26MQ1 2023: $17.8MQ2 2023: $22.0MQ3 2023: $9.99MQ4 2023: $14.7MQ1 2024: $294.6MQ2 2024: $384.9MQ3 2024: $654.9MQ4 2024: $150.7MQ1 2025: $96.4MQ2 2025: $146.3MQ3 2025: $150.1MQ4 2025: $105.0MQ1 2026: $333.1MQ2 2026: $297.6M
Institutions holding CATX and their total value by quarter
QuarterHoldersValue
Q2 2026131$297.6M
Q1 2026138$333.1M
Q4 2025117$105.0M
Q3 2025105$150.1M
Q2 202598$146.3M
Q1 2025112$96.4M
Q4 2024135$150.7M
Q3 2024127$654.9M
Q2 2024105$384.9M
Q1 2024104$294.6M
Q4 202352$14.7M
Q3 202349$9.99M
Q2 202350$22.0M
Q1 202342$17.8M
Q4 202248$4.26M
Q3 202235$3.70M
Q2 202243$5.19M
Q1 202239$5.79M
Q4 202145$6.78M
Q3 202143$9.99M
Q2 202148$13.9M
Q1 202157$20.2M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding CATX in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc2,921,268$29.1M0.00%−14,858,838−83.6%Reduced
Avidity Partners Management LP3,037,668$30.3M1.29%+3,037,668New
BlackRock Inc.3,485,946$34.8M0.00%−4,408,739−55.8%Reduced
Janus Henderson Group PLC4,443,667$44.0M0.02%−8,645,809−66.1%Reduced
Commodore Capital LP4,657,345$46.4M3.17%−16,395,286−77.9%Reduced
Hills Bank & Trust Co0$00.00%−10,358,305−100.0%Sold out
Laurion Capital Management LP0$00.00%−8,918,918−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−1,996,511−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−850,000−100.0%Sold out
Tri Locum Partners LP0$00.00%−780,303−100.0%Sold out
Mayo Clinic0$00.00%−724,641−100.0%Sold out
Atom Investors LP0$00.00%−551,279−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−535,293−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−527,470−100.0%Sold out
Taylor & Morgan Wealth Management, LLC0$00.00%−250,000−100.0%Sold out
Baker Bros. Advisors LP0$00.00%−149,787−100.0%Sold out
HRT Financial LP0$00.00%−122,167−100.0%Sold out
Virtu Financial LLC0$00.00%−115,762−100.0%Sold out
LMR Partners LLP0$00.00%−115,488−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−111,723−100.0%Sold out
Polymer Capital Management (HK) LTD0$00.00%−103,773−100.0%Sold out
Ameriprise Financial Inc0$00.00%−93,201−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−80,000−100.0%Sold out
CTC Alternative Strategies, Ltd.0$00.00%−69,900−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−48,284−100.0%Sold out
Mariner, LLC0$00.00%−47,778−100.0%Sold out
Marathon Trading Investment Management LLC0$00.00%−47,000−100.0%Sold out
Omers Administration Corp0$00.00%−45,200−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−43,500−100.0%Sold out
Thrivent Financial for Lutherans0$00.00%−40,000−100.0%Sold out
Cerity Partners LLC0$00.00%−40,000−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−38,994−100.0%Sold out
Simplicity Wealth,LLC0$00.00%−33,570−100.0%Sold out
Bleakley Financial Group, LLC0$00.00%−33,570−100.0%Sold out
Squarepoint Ops LLC0$00.00%−28,990−100.0%Sold out
TradeLink Capital LLC0$00.00%−27,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−23,100−100.0%Sold out
HighPoint Advisor Group LLC0$00.00%−15,700−100.0%Sold out
ZWJ Investment Counsel Inc0$00.00%−22,000−100.0%Sold out
Wealth Advisors of Iowa, LLC0$00.00%−20,000−100.0%Sold out
Raymond James Financial Services Advisors, Inc.0$00.00%−18,450−100.0%Sold out
Congress Wealth Management LLC0$00.00%−15,000−100.0%Sold out
Prudential Financial Inc0$00.00%−14,400−100.0%Sold out
Twinbeech Capital LP0$00.00%−14,377−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−14,152−100.0%Sold out
Cetera Investment Advisers0$00.00%−12,500−100.0%Sold out
Great Valley Advisor Group, Inc.0$00.00%−12,000−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−10,881−100.0%Sold out
Auxier Asset Management0$00.00%−10,218−100.0%Sold out
Capital Advisors Inc0$00.00%−10,000−100.0%Sold out
Old Point Trust & Financial Services N A0$00.00%−2,500−100.0%Sold out
Scarborough Advisors, LLC0$00.00%−109−100.0%Sold out
Macquarie Group Ltd0$00.00%−13,988−100.0%Sold out
Mercer Global Advisors Inc0$00.00%−4−100.0%Sold out
RIA Advisory Group LLC––––Not filed